Pharmaceutical Water and Its Critical Role in Biopharmaceutical Manufacturing

 

Pharmaceutical water is a vital component in biopharmaceutical manufacturing, playing a critical role in various processes, from drug formulation to cleaning and sterilization. Water quality directly impacts the safety, efficacy, and consistency of pharmaceutical products. The stringent regulatory standards set by agencies such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and the World Health Organization (WHO) underscore the importance of maintaining high purity levels. This article explores the types, production, regulatory requirements, and significance of pharmaceutical water in biopharmaceutical manufacturing.

Global pharmaceutical water industry, valued at US$ 37.1 billion in 2023, is expected to grow at a CAGR of 8.3% from 2024 to 2034, reaching US$ 89.9 billion by 2034.
Increase in demand for pharmaceutical production and continuous implication of regulatory compliance and quality standards is fueling the global pharmaceutical water market trajectory. Pharmaceutical water is essential in drug formulation, manufacturing, and research, as specific grades, such as Water for Injection (WFI) and Purified Water, are vital to ensuring the efficacy and safety of medicines.

Types of Pharmaceutical Water

There are multiple grades of pharmaceutical water, each designed for specific applications in biopharmaceutical manufacturing. The most commonly used types include:

1.    Purified Water (PW) – Used in the preparation of non-sterile pharmaceutical products, cleaning, and as a raw material in drug formulation.

2.    Water for Injection (WFI) – Highly purified water free from pyrogens, used in the production of parenteral drugs and cleaning processes.

3.    Highly Purified Water (HPW) – Used in processes requiring extremely high purity, such as ophthalmic and inhalation solutions.

4.    Sterile Water for Injection (SWFI) – Used as a diluent for injectable drugs and must be free from microbial contamination.

5.    Bacteriostatic Water for Injection (BWFI) – Contains antimicrobial agents and is used in multiple-dose injections.

6.    Water for Hemodialysis – Specially treated water used in dialysis treatments to prevent contamination in the bloodstream.

Each type of water has stringent quality specifications, requiring advanced purification processes to meet regulatory standards.

Production and Purification Processes

The production of pharmaceutical water involves multiple purification technologies to remove contaminants, microorganisms, and endotoxins. Some of the most common purification methods include:

•    Reverse Osmosis (RO): Uses semi-permeable membranes to remove dissolved salts, bacteria, and other impurities.

•    Distillation: A process that involves boiling water to produce steam, then condensing it back into liquid form to ensure high purity.

•    Ultrafiltration: Removes particles and high molecular weight substances such as pyrogens and endotoxins.

•    Deionization (DI): Utilizes ion-exchange resins to remove charged particles, including heavy metals and minerals.

•    UV Radiation: Used for microbial control by disrupting the DNA of bacteria and viruses.

A combination of these methods ensures that pharmaceutical water meets the necessary purity standards for its intended use.

Regulatory Standards and Compliance

Regulatory agencies have established strict guidelines to ensure the safety and efficacy of pharmaceutical water. Some key standards include:

•    USP <1231> Water for Pharmaceutical Purposes: Provides guidelines on the production, quality, and validation of pharmaceutical water.
•    EP Monographs: Defines specifications for different grades of pharmaceutical water in Europe.
•    WHO Guidelines: Outlines best practices for pharmaceutical water systems, particularly for WFI and PW.
•    Good Manufacturing Practices (GMP): Ensures that water systems are validated and consistently produce high-quality water.
Manufacturers must implement routine monitoring, validation, and documentation practices to comply with these regulatory requirements.

Role of Pharmaceutical Water in Biopharmaceutical Manufacturing

Pharmaceutical water is integral to every stage of biopharmaceutical manufacturing. Its applications include:

1. Drug Formulation

Water serves as a solvent in the preparation of liquid, injectable, and ophthalmic drugs. The purity of water ensures that there are no contaminants that could affect drug stability or patient safety.

2. Cleaning and Sterilization

High-purity water is used for cleaning production equipment, vessels, and surfaces in pharmaceutical facilities. Proper sterilization prevents cross-contamination and maintains aseptic conditions.

3. Cell Culture and Bioprocessing

In biopharmaceutical manufacturing, water is used in cell culture media preparation, buffer solutions, and upstream processing. High-purity water prevents microbial growth and ensures optimal conditions for cell development.

4. Parenteral Drug Production

Water for Injection (WFI) is essential for the manufacture of intravenous drugs, vaccines, and biologics. Its pyrogen-free nature is crucial for patient safety.

5. Quality Control and Analysis

Pharmaceutical water is used in analytical laboratories for sample preparation, reagent formulation, and instrument calibration, ensuring accuracy in quality control tests.

Challenges and Considerations in Pharmaceutical Water Systems

1. Microbial Contamination

Maintaining microbial control in pharmaceutical water systems is critical. Bacteria and biofilm formation can compromise water quality, necessitating regular sanitization and monitoring.

2. System Design and Maintenance

Pharmaceutical water systems must be designed with minimal dead legs, proper flow rates, and appropriate material selection to prevent contamination and corrosion.

3. Regulatory Compliance

Manufacturers must continuously validate water systems, conduct risk assessments, and adhere to evolving regulatory requirements to maintain compliance.

4. Energy and Resource Efficiency

Water purification is energy-intensive, requiring strategies to optimize energy use and reduce waste. Implementing closed-loop systems and recycling water can improve sustainability.

Future Trends in Pharmaceutical Water Systems

1. Advanced Purification Technologies

Innovations in Nano filtration, membrane bioreactors, and electro-deionization are enhancing the efficiency and sustainability of pharmaceutical water systems.

2. Automation and Real-Time Monitoring

The integration of automated monitoring systems and real-time analytics is improving quality control, reducing contamination risks, and ensuring regulatory compliance.

3. Sustainable Water Management

As environmental concerns grow, pharmaceutical manufacturers are investing in water reuse, desalination, and green technologies to minimize water consumption and reduce waste.

4. Regulatory Evolution

Regulatory bodies are continuously updating guidelines to incorporate new scientific insights and technological advancements in pharmaceutical water systems.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Water Industry

Author

Kaustubh Ravan is a passionate market research analyst and writer specializing in emerging industry trends and market dynamics. With expertise in diverse sectors, he delivers in-depth insights and data-driven reports. His work helps businesses navigate evolving markets and make informed decisions. Kaustubh analytical approach and keen industry foresight make him a trusted voice in market research.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

How to Ensure an ISO Certificate Is Authentic and Valid?

ISO certification is a big deal for businesses. It shows that they meet international standards for quality, safety, and efficiency. But what if the certificate is fake? Yes, that happens more often than you’d think! So the question is how do you ensure an ISO certificate is authentic and valid? Let’s simplify this in simple terms.

By Emily Andersen

Why Verify an ISO Certificate?

Think about it. Would you trust a doctor with a fake degree? No right? The same logic applies to businesses. An invalid or fake certificate can lead to serious consequences for a business—legal issues, loss of credibility, and financial losses. So, before working with a company that claims to have an ISO certificate, always verify it.

How to Check ISO Certificate Validity

Follow these simple steps to verify an ISO certificate of a business:


Check the Certifying Authority


ISO does not issue certificates itself. It is independent certifying bodies that do it. Check the name of the certifying body. If it’s missing or sounds suspicious, that’s a red flag.


Cross-Check the Certifying Body


Once you have noted the name, visit the official website of the certifying body. Most legitimate certifiers have a certification verification tool on their website. Enter the certificate number to check its validity.


Tally with ISO Certificate Verification Websites


The next step is to verify whether the ISO certificate is listed in the official databases where accredited ISO certificates are listed. Some trusted sources include:


International Accreditation Forum (IAF)


Accreditation Bodies Websites - Each country has an official accreditation body that can verify certificates.


The Certification Body’s Website - Use the search tool on the website of the certifying body.


Inspect the Accreditation Status


A real ISO certificate should be issued by a certification body that is accredited by an official accreditation body. For example, in the U.S., it’s ANAB. In the UK, it’s UKAS. If there is no accreditation, you should be sceptical.


Analyze the Certificate Details


A genuine ISO certificate will consist of:

• Company name and address
• Certification number
• Issue and expiry dates
• Standard(like ISO 9001, ISO 14001, etc.)
• Certifying body’s logo and accreditation details

If any of these details are missing or improper, double-check with the issuing body.

Contact the Issuing Body

A second level of verification would be to call the certifying authority directly or send an email to them. Ask them if the certificate is real. If they act dodgy or suspicious, there’s a chance their certificate is fake.

Verify on the Company’s Website

Legitimate businesses proudly display their ISO certifications. Log on to their website. If they claim to have certification but don’t display details online, ask them for the actual certificate.

Be Wary of Fake Logos and Bad Printing

Some scammers play tricks like using a fake ISO logo on their website or document. Remember, ISO never allows companies to use its logo. Other signs of fake certificates are poor-quality printing, missing security features, or altered text.

Check the Expiry Date

ISO certificates don’t last forever. They usually expire within 3 years but even before the end of this period, annual surveillance audits are required. If the certificate has expired and not renewed, it becomes invalid.

Use Common Sense

Trust your instinct to detect whether an ISO certificate is fake. For instance, if a company is offering unbelievably cheap services and using an ISO certificate to gain your trust, dig deeper. Scammers rely on people not verifying details.

Why Fake ISO Certificates Exist

The main purpose of faking an ISO certificate is to appear credible and attract customers. Here’s why:

• They want to win contracts without going through the real certification process.
• They want to charge higher prices by faking quality standards.
• They know most people won’t verify the certificate.

That’s why ISO certificate verification is a must!

Consequences of Using a Fake ISO Certificate

If a company is caught using a fake ISO certificate, the consequences can be brutal:

• Legal trouble - Authorities may take action for fraud.
• Destroyed reputation - No one trusts fraudulent companies
• Financial losses - Fines, lost business, and lawsuits.
• Business ban - Some industries blacklist companies with fake certifications.

Wrapping Up

An ISO certificate shows that a company is trustworthy and reliable. A fake certificate does the exact opposite. That’s why you must check the ISO certificate validity of a company before trusting it. Use the steps above, verify through official sources and never assume an ISO claim to be true.


Being smart about ISO verification protects your business, reputation, and money. Stay vigilant to avoid scams!

 

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Treating anthrax beyond the 'point of no return'

Source: CDC - This media comes from the Centers for Disease Control and Prevention's Public Health Image Library (PHIL), with identification number #2226

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the "point of no return" after just a few days, patients are most likely to die.

In a new study, University of Pittsburgh researchers show that a cocktail of growth factors reversed would-be lethal cell damage in mice with anthrax, suggesting that this approach could be adapted for use in patients beyond the brink.

When B. anthracis enters the body through inhalation, ingestion, injection or contact with skin, it produces two proteins that combine to form lethal toxin.

Early on, anthrax can be treated with antibiotics that eliminate the bacterium or antibodies that neutralize lethal toxin before it enters cells. But once inside cells, the toxin inactivates members of a group of enzymes known as MEKs by cleaving off one of their ends, disrupting the important pathways they control and rapidly causing widespread cellular, tissue and organ damage -- and death.

To learn more about the roles of MEK-controlled pathways in anthrax toxicity,the researchers generated mice with modified MEKs that were resistant to being cleaved by lethal toxin. These included MEK1 and MEK2, which control a pathway called ERK involved in cellular division and survival, and MEK3 and MEK6, which regulate the p38 pathway that's involved in stress-induced defense.

When exposed to lethal toxin or B. anthracis, mice with either modified MEK1/2 or MEK3/6 had much greater survival than normal animals, indicating that anthrax must inactivate both the ERK and p38 pathways to kill its host.

In mice and human cells exposed to lethal toxin or B. anthracis, a combination of three growth factors -- all individually approved as treatments for other conditions -- reactivated the ERK pathway and brought them back from the point of no return.

Because different types of cells in the body may require different growth factors to activate ERK, the researchers are now working to optimize a treatment for anthrax in humans.

See: 

Liu, J., Zuo, Z., Ewing, M. et al. ERK pathway reactivation prevents anthrax toxin lethality in mice. Nat Microbiol, 2025 DOI: 10.1038/s41564-025-01977-x

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

How do you explain the difference between a Quality Policy and a Quality Objective?

You're no stranger to the terms "Quality Policy" and "Quality Objectives," but how easy is it to convey their meaning - and their difference - to others in your organization?

By Lesley Worthington.
​
The challenge lies in articulating these concepts so that they're as clear to the others as they are to you.
​
Here are some ideas:

• Quality Policy: Think of explaining the Quality Policy as the organization’s promise about quality. It’s the big-picture statement that says, “Here’s what quality means to us, and here’s the direction we’re headed.” You could explain it to others by saying, “It’s like our quality compass—it keeps us pointed in the right direction and aligned with what the company stands for.” Bonus: Tie it back to the company’s mission or values so it feels even more relevant.
  ​
• Quality Objectives: These are the stepping stones that help us fulfill the Quality Policy. They’re specific, measurable goals that show how we’re making progress toward that promise. To explain it simply, you could say, “Think of these as our quality scorecards—they help us track how well we’re delivering on our quality commitment. And just like business goals, they’ll shift and evolve to keep up with the company’s priorities.”

One quick tip for engaging upper management: Always try to tie these terms back to the business strategy. That's what they care about. And that might make them sit up and pay attention. Make it clear that a well-articulated Quality Policy and measurable Quality Objectives are not just quality goals but business imperatives.
​
If an objective is too vague like "Improve customer satisfaction," help them refine it. Suggest a measurable alternative, such as "Increase customer retention rates by 10% this quarter." This gives everyone in the organization a concrete, trackable goal to aim for.
​
The better we can articulate these key quality terms, the easier it will be to get buy-in from everyone - from the C-suite to those on the shop floor.

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Why here? Why now? Protein-triggering bacteria spore formation characterized

A protein that enables bacteria to shut down into dormant spores under extreme conditions has been discovered. Sporulation is an effective survival mechanism, a state of dormancy, that some types of bacteria can enter into.

While many bacteria can tolerate harsh environments (like endolithic microorganisms, obtaining their energy and nutrients from rocks), the most extreme environments require sporulation to maintain survival. The process of sporulation enables bacteria to become very resistant to heat and radiation, creating life capsules for bacteria to survive in uninhabitable places including the most extreme places on the planet, such as under the permafrost, in the depths of the ocean or outer space (as some space missions have shown).

Discovering a new protein involved in sporulation in a group of bacteria could further our understanding of bacteria's ability to survive and potentially open up new avenues for antimicrobial therapies.

In this week’s article, the new research into the sporulating trigger protein is highlighted as well as an overview of some general aspects of bacterial sporulation. 

See: LinkedIn article

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

GMP Society

The GMP Society is an international organisation for Good Manufacturing Practices (GMPs) “Quality Professionals” to grow professionally and interact with like-minded individuals. We provide a forum for the free exchange of ideas and information to improve the production of pharmaceutical (medicinal) drug products.

Our member-led organisation affirms and promotes the principles of GMPs in all our professional activities by:

• Striving to protect the integrity of the pharmaceuticals we produce;
• Creating an environment where all products manufactured for human and veterinary use are of superior quality to confirm the well-being of the patient who uses our products;
• Providing training programs and certification programs to educate professionals with recognised, superior qualifications as we facilitate the development of GMP quality professionals in all markets, especially developing nations and regions;
• Fostering an environment of support to sustain not only our own companies, but all the companies manufacturing APIs and drug products for human and animal use;
• Working towards creating one international GMP standard for drug products and become recognised as a primary voice for GMP standard settings by regulatory authorities;
• Providing opportunities and benefits for our members in:
  • Information sharing and networking
  • Training
  • Education
  • Career development and
  • Personal advancement opportunities

Through our analysis and official documents, we will analyze international pharmaceutical regulations to provide compliance insight and focus for proper implementation, where appropriate. Communication among members is facilitated by active blogs, workshops, training programmes, conferences, GMP Review journal and our book publication program(s). 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Different Flow Hoods and How They Are Used in Experiments

                                                     Working in a laminar airflow cabinet. Image by Tim Sandle

What is a flow hood? It's a controlled environment created to minimize contamination, and it does this by directing filtered air over the designated workspace. Flow hoods are also known as clean benches or laminar flow hoods. Regardless of what name they go by, they're frequently used in laboratories to provide a sterile environmental setting for experiments by protecting researchers, equipment, and samples from airborne contaminants. Particle removal happens through ultra-low penetration air or high-efficiency particulate air filters before the air comes into the workspace. Flow hoods are available in several categories, and knowing their differences is crucial to picking the best hood for a particular application.

Different Flow Hoods and Their Uses in Experiments

You can find a variety of flow hoods for different applications. Knowing the primary categories helps you sift through your options.

Laminar Flow Hoods

A laminar flow hood makes a steady stream of filtered air. This stream moves continuously in a single direction to keep contamination from happening. Laminar flow hoods come in both horizontal and vertical configurations. Horizontal models direct clean air across a work surface and toward the user, and they're often used in pharmaceutical research, electronics assembly, and microbiology. Vertical models push filtered air down to the work surface to keep contaminants off of users; these are ideal for sample preparation and tissue culture work.

Biological Safety Cabinets

BSCs are intended to protect experiments, users, and the surrounding environment around them. HEPA filtration captures hazardous particles. Biohazard exposure is further prevented by airflow containment systems. BSCs are available in three different classes with varying levels of environmental protection. The highest levels of containment are totally enclosed and feature glove ports for handling dangerous pathogens.

Fume Hoods

Fume hoods aren't designed to be sterile, but they can prove important for any experiment that involves volatile chemicals. Users are protected when hazardous fumes get drawn away from a workspace and vented safely outside. Chemistry laboratories frequently employ these to minimize exposure to many different toxic substances.

PCR Workstations

Polymerase chain reaction workstations are a special category of laminar flow hoods. These are intended to minimize DNA contamination when amplification processes are underway. UV light is a common sterilization technology between experiments.

What To Watch Out for With Flow Hoods

There are several considerations to be mindful of with flow hoods. First, airflow disruptions can reduce effectiveness when objects are placed incorrectly in a flow hood. Secondly, ULPA and HEPA filters degrade with the passage of time; regular checks and replacements are essential to maintaining proper efficiency and function. Third, work practices need to be good habits in terms of avoiding rapid movements that might introduce contaminants or opening and closing flow hoods too frequently.

Proper hood selection is always important. Using the wrong kind of hood for your experiments might compromise the final results. For instance, don't use laminar flow hoods when working with hazardous materials. A biological safety cabinet is the more appropriate choice.

Protect Your Experiments

Flow hoods are important to experimental settings because they offer controlled environments with improved precision and safety. Choose the appropriate hood for your conditions and maintain it properly for reliable performance in laboratory settings and research applications.

Written by Taylor McKnight, Author for Cleatech LLC

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Will ethanol be banned in Europe as the active ingredient for hand disinfectants?

Image by Tim Sandle

With ethanol be banned in the EU as the basis for hand disinfection? Do epidemiological studies confirm an increased risk for cancer from ethanol in exposed individuals? Why is the EU considering this move now?

I've noticed this report from Chemistry World:

Medical experts and health organisations from around the world have expressed concern over what they say would be a ‘misclassification’ of ethanol as a reprotoxic substance when it appears in biocidal products such as hand gels. They say there is no scientific evidence for the reclassification, which would result in significant risks to public health and safety if vital disinfectants were unavailable.

Disinfectant hand gels containing ethanol might no longer be available if the compound is reclassified as toxic to reproduction

The EU’s evaluation of ethanol’s use in products such as hand gels and disinfectants under the Biocidal Products Regulation (BPR) was assigned to Greek authorities back in 2007. In March, they submitted their draft report to the European Chemicals Agency (Echa) proposing that ethanol should be listed as a reprotoxic category 2 active substance (category 1 is the highest classification). This means it is a suspected human reproductive toxicant and follows some evidence of an adverse effect on sexual function and fertility, or on development. If ethanol was reclassified as a category 2, then biocides containing more than 3% would have to be labelled as reprotoxic. Effective hand-sanitising gels contain at least 60% alcohol.

Echa’s Biocidal Products Committee (BPC) is reviewing the report. Hanna-Kaisa Torkkeli, an Echa spokesperson, says it’s too early to predict the outcome, but expects an ‘opinion’ at the end of 2024 or, more likely, in 2025. The European Commission will make a final recommendation based on the BPC’s opinion.

To read the full article, see Chemistry World. 

In relation to this topic, this research paper, from 2024, concludes "There is no epidemiological evidence of toxicity for workers handling ethanol-containing products in industry or using EBHR in healthcare settings." EBHR = ethanol-based hand rubs.

Also see:  "Medical associations and expert committees urge that ethanol be approved as a virucidal active substance for use in hand antiseptics under the European Biocidal Products Regulation, without a CMR classification".

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Microbiome new study: Human ancestral co-evolution

 Meta-organism entangled metabolic pathway of microbial 3M3SH malodor biotransformation steered by human precursor thiol conjugate substrate in ABCC11 haplotypes. Scientific Reports (Sci Rep) ISSN 2045-2322 (online)

A new microbiome study of interest.

The project concerns the evolutionary roots of human ancestral ethnic group global regionalizations, as involving skin niche microbial communities.

We address humans as “meta-organism” entities—i.e., entangled conglomerates of microbe genomes plus Homo sapiens genomes that have co-evolved through symbiotic mutualism.

The study asks the existential question: who is the evolutionary driver that steered modern humans into becoming such a meta-organism—was it people or microbes? How has survival advantage steered the ancient human origins of geographic regional clustering of ancestral ethnic groups with signature microbiomes?

Our data center on the key role of a microbe unique to humans, Staphylococcus hominis, and its engineering of “selfish gene” propagation opportunities by way of steering social interactions and communicable contacts among it’s human hosts whom are relegated as mere Trojan horse delivery vessels and incubators subserving their microbial companions. Within an extended family tree, this bacterial species is either inherited or not inherited by individuals, as governed by SNP variants of the human ABCC11 gene responsible for body odor vs. no odor binary pheromone communication.

The paper is:

Stevens, B.R., Roesch, L.F.W. Interplay of human ABCC11 transporter gene variants with axillary skin microbiome functional genomics. Nature Sci Rep 14, 28037 (2024).

Publisher’s link: https://doi.org/10.1038/s41598-024-78711-w .

You can jump to Fig. 6 for an overview lay summary.

A reprint PDF with additional Supplementary content is set out below:

Interplay of Human ABCC11 Transporter Gene Variants With Axillary Skin Microbiome Functional Genomic 2024 N... by Tim Sandle on Scribd

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)